Vascular endothelial growth factor (VEGF)-A and VEGF-A

Effective prognostic markers are needed for antineutrophil cytoplasmic antibody-associated vasculitis (AAV). This study evaluated the clinical associations of serum vascular endothelial growth factor-A (sVEGF-A) and sVEGF-AWe collected samples from patients with AAV who were enrolled in the nationwide Japanese cohort study (RemIT-JAV-RPGN). We measured sVEGF-A and sVEGF-AResults revealed significant reductions in sVEGF-A and sVEGF-AThese results suggest that sVEGF-A and -A